HIV infection and rheumatic diseases: the changing spectrum of clinical enigma.
In this article, the authors discuss the occurrence and prevalence of rheumatic syndromes before and after highly active antiretroviral therapy became the usual mode of treatment. The immunologic, environmental, and genetic factors behind the combination of HIV infection and rheumatic manifestation contribute to the complexity of these diseases. Miscellaneous case reports are discussed in relation to HIV infection. The authors conclude that geriatric care of HIV patients is on the horizon as more people have access to newer, more effective therapy and mortality is on the decline. Younger HIV patients will be committed to a lifetime of therapy to address bone disease and other chronic problems. In the future, newer agents may steer the clinical scenario in unforeseen directions.
Patel
Nirupa
N
Section of Rheumatology, Louisiana State University Health Sciences Center, 2020 Gravier Street, 7th Floor, Rm 719/7D4, New Orleans, LA 70065, USA.
Patel
Neej
N
Espinoza
Luis R
LR
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D000998:Antiviral Agents / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000139:chemically induced; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy; D012216:Rheumatic Diseases / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology
D000998:Antiviral Agents